Maryland-based biotech NextCure is looking for partners to advance a candidate for the currently incurable rare disease osteogenesis imperfecta (OI) after the asset strengthened bones and reduced ...
Viana Kelly is relieved to roll into Nemours Children's Hospital in Wilmington, Delaware, with her 1-year-old baby, Koa. "I walk in here every time not worried about his care," Kelly said. Koa has ...
Hosted on MSN
NextCure Stock Soars After-Hours On Promising Preclinical Data For Rare Bone Disease Treatment
NextCure, Inc. stock surged nearly 45% in Thursday's extended trading session after the biopharma firm unveiled new preclinical results showing its experimental antibody may offer a more effective ...
Baylor College of Medicine has received new funding from the National Institutes of Health for two consortia in the Rare Diseases Clinical Research Network: $7.4 million over five years to renew the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback